Participants cannot remain blind to their treatment arm due to the properties of...
While some biotechs are attempting to develop disease-modifying therapies for am...
While Lilly’s Alzheimer’s drug was previously expected in Q1 2024, an FDA-mandat...
The FDA has already granted accelerated approvals to several third-line treatmen...
The company revealed the data at the Alzheimer’s Disease and Parkinson’s Disease...
Amylyx’s stocks plummeted by more than 85% after announcing it is considering sc...
CPI’s new Oligonucleotide Manufacturing Innovation Centre of Excellence in Scotl...
SK bioscience has broken ground on a significant expansion of its vaccine manufa...
Johnson & Johnson (J&J) has concluded the acquisition of Ambrx Biopharma in a tr...
The US FDA has granted approval for BMS' Opdivo for the first-line treatment of ...
Beyfortus, a new shot for RSV, was 90% effective at preventing hospitalizations ...
Ahead of the Oscars and amid shortages, Lilly is running a new ad campaign urgin...
A congressional bill is meant to effectively ban certain Chinese life sciences c...
A New York jury has convicted the former CEO of Stimwave, a company that sold de...
Amylyx's ALS drug failure leaves patients, advocates, and researchers reeling — ...
Wegovy, already approved for obesity, can now say it also benefits the heart. Th...
